We propose that all women of Orcadian ancestry (worldwide) with a diagnosis of breast cancer should be offered a targeted test for this variant, if a BRCA1/BRCA2 gene screen is not offered as part of their clinical care. The gene discussed is BRCA1; the disease is breast carcinoma.